Skip to main content

Drug Susceptibility Screening Using In Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria

  • Protocol
  • First Online:
Mycobacteria Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2314))

Abstract

Non-replicating persistence (NRP) is a functional adaptation that mycobacteria undergo in response to the stresses of the granuloma, facilitating antibiotic tolerance and long-term infection. These stresses, or NRP-inducing factors, include hypoxia, nutrient deprivation, and nitric oxide assault, which mycobacteria are well evolved to tolerate through a series of metabolic and physiological adaptations producing the NRP state. Most attempts to replicate these conditions in vitro have focused on only one of these factors at a time for ease and simplicity, but as a result, do not necessarily produce physiologically relevant phenotypes. Here, we provide the methods for two different in vitro NRP strategies that are useful for drug susceptibility testing and high-throughput screening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wayne LG, Sohaskey CD (2001) Nonreplicating persistence of Mycobacterium Tuberculosis. Annu Rev Microbiol 55:139–163

    Article  CAS  Google Scholar 

  2. Gibson SER, Harrison J, Cox JAG (2018) Modelling a silent epidemic: a review of the in vitro models of latent tuberculosis. Pathogens 7(4):88. https://doi.org/10.3390/pathogens7040088

    Article  CAS  PubMed Central  Google Scholar 

  3. Martin CJ, Carey AF, Fortune SM (2016) A bug’s life in the granuloma. Semin Immunopathol 38:213–220

    Article  CAS  Google Scholar 

  4. Parish T, Stoker NG, Wayne LG (2003) In vitro model of hypoxically induced nonreplicating persistence of Mycobacterium tuberculosis. Methods Mol Med 54:247–269. https://doi.org/10.1385/1-59259-147-7:247

    Article  Google Scholar 

  5. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43:717–731

    Article  CAS  Google Scholar 

  6. Wipperman MF, Sampson NS, Thomas ST (2014) Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49:269–293

    Article  CAS  Google Scholar 

  7. Voskuil MI, Schnappinger D, Visconti KC et al (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198:705–713

    Article  CAS  Google Scholar 

  8. Griffin JE, Pandey AK, Gilmore SA et al (2012) Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol 19:218–227

    Article  CAS  Google Scholar 

  9. Schnappinger D, Ehrt S, Voskuil MI et al (2003) Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the Phagosomal environment. J Exp Med 198(5):693–704. https://doi.org/10.1084/jem.20030846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Houben RMGJ, Dodd PJ (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 13:e1002152

    Article  Google Scholar 

  11. WHO (2019) Global TB Rep 2019

    Google Scholar 

  12. Wayne LG, Hayes LG (1996) An in vitro model for sequential study of Shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64(6):2062–2069

    Article  CAS  Google Scholar 

  13. Cho SH, Goodlett D, Franzblau S (2006) ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis 86:445–460

    Article  CAS  Google Scholar 

  14. Dickinson JM, Aber VR, Mitchison DA (1977) Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium tuberculosis. Am Rev Respir Dis 116:627–635

    Article  CAS  Google Scholar 

  15. Cho SH, Warit S, Wan B et al (2007) Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 51:1380–1385

    Article  CAS  Google Scholar 

  16. Amsterdam D (2005) Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 5th edn. Lippincott Williams & Wilkins, PA, USA

    Google Scholar 

  17. Velayati AA, Farnia P, Masjedi MR et al (2011) Sequential adaptation in latent tuberculosis bacilli: observation by atomic force microscopy (AFM). Int J Clin Exp Med 4:193–199

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Jakkala K, Ajitkumar P (2019) Hypoxic non-replicating persistent Mycobacterium tuberculosis develops thickened outer layer that helps in restricting rifampicin entry. Front Microbiol 10:2339

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan A. G. Cox .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Gibson, S.E.R., Harrison, J., Cox, J.A.G. (2021). Drug Susceptibility Screening Using In Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria. In: Parish, T., Kumar, A. (eds) Mycobacteria Protocols. Methods in Molecular Biology, vol 2314. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1460-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1460-0_10

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1459-4

  • Online ISBN: 978-1-0716-1460-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics